The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Bil Schmidtknecht blames pharmacy benefit managers for the death of his son. He won’t rest until he holds them accountable.

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the future.

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

The sweeping One Big Beautiful Bill Act, signed into federal law July 4, amended CMS’ drug price negotiations authority that could absolve nearly $5 billion in projected savings, according to the ...

President Trump is attempting to reshape America’s biotech industry with two primary objectives. He wants more medicines to ...

Duyen Ha Vo, senior partner, Vilaf Finished pharmaceutical products were initially excluded from US President Donald Trump’s reciprocal tariff regime announced in April. However, President Trump ...